|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/50 | |
| A61K 31/7048 | |||
| A61J 3/06 | |||
| A61K 9/70 |
| (11) | Number of the document | 2968181 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14763925.6 |
| Date of filing the European patent application | 2014-03-14 | |
| (97) | Date of publication of the European application | 2016-01-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/029168 |
| Date | 2014-03-14 |
| (87) | Number | WO 2014/144661 |
| Date | 2014-09-18 |
| (30) | Number | Date | Country code |
| 201361791592 P | 2013-03-15 | US |
| (72) |
JACOB, Jules, US
BEACH, Lauren, US
WEST, Thomas, G., US
MONKHOUSE, Donald, C., US
SURPRENANT, Henry, L., US
|
| (73) |
Aprecia Pharmaceuticals LLC,
10901 Kenwood Road, Blue Ash, OH 45242,
US
|
| (54) | RAPIDLY DISPERSIBLE DOSAGE FORM OF TOPIRAMATE |
| RAPIDLY DISPERSIBLE DOSAGE FORM OF TOPIRAMATE |